Table 3.
Comparison | Input model |
DLBCL | NSCLC | ||
---|---|---|---|---|---|
C-index | P-value | C-index | P-value | ||
Lesion-ROI subgroup | All features, all lesion-ROI | 0.84 ± 0.04 | < 0.001 | 0.71 ± 0.03 | < 0.001 |
5 biggest lesion-ROI | 0.78 ± 0.06 | < 0.001 | 0.67 ± 0.03 | 0.006 | |
1 hottest lesion-ROI | 0.77 ± 0.05 | < 0.001 | 0.68 ± 0.03 | < 0.001 | |
Feature subgroup | All features, all lesion-ROI | 0.84 ± 0.04 | < 0.001 | 0.71 ± 0.03 | < 0.001 |
BL + FU + Patient-level Response | 0.67 ± 0.06 | 0.03 | 0.70 ± 0.03 | < 0.001 | |
FU | 0.64 ± 0.08 | 0.2 | 0.65 ± 0.03 | < 0.001 | |
BL | 0.67 ± 0.06 | 0.03 | 0.64 ± 0.03 | < 0.001 | |
Previously Established Predictors | All features, all lesion-ROI | 0.84 ± 0.04 | < 0.001 | 0.71 ± 0.03 | < 0.001 |
RECIST | 0.59 ± 0.05 | 0.14 | 0.50 ± 0.01 | 0.47 | |
PERCIST | 0.58 ± 0.05 | 0.2 | 0.51 ± 0.01 | 0.51 | |
Deauville | 0.62 ± 0.07 | 0.25 | - | - | |
Global SUVpeak2 | - | - | 0.57 ± 0.03 | 0.01 | |
Global Volume 1 | - | - | 0.62 ± 0.03 | < 0.001 | |
Percent Change Global SUVmax | 0.58 ± 0.06 | 0.3 | - | - |